© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
May 04, 2021
More opportunities are emerging for pharmacists to fine-tune their patients’ regimens and serve as important access points for individuals experiencing mental health crises.
April 20, 2021
The study will be presented today during the 2021 American Academy of Neurology Annual Meeting.
October 15, 2020
The joint committee’s recommendations will be considered by the FDA in the drug candidate’s new drug application.
August 04, 2020
The FDA approved a cannabidiol oral solution treatment (Epidiolex, Greenwich Biosciences) for seizures associated with tuberous sclerosis complex.
July 27, 2020
Responding to growing interest by industry stakeholders, the agency has offered draft guidance outlining quality considerations and other practical recommendations for cannabis and cannabis-derived compounds.
Health care professionals should consider prescribing naloxone to patients taking prescribed opioids who are at increased risk of opioid overdose, according to the FDA.
July 24, 2020
Eighty-one percent of opioid abuse referrals to post-acute care facilities in Massachusetts were rejected, investigators found.
June 30, 2020
Though the relationship between genetics and gut-dwelling bacteria is still a realm of mystery, new research has begun a new step towards better understanding how one affects the other.
June 17, 2020
FDA approval for the secukinumab (Cosentyx, Novartis) for non-radiographic axial spondyloarthritis was based on results from the PREVENT trial, which showed significant reduction in disease activity.
July 13, 2017
Preventing drug-drug interactions with HIV ART